BioNTech Historical Balance Sheet

BNTX Stock

USD 121.16 3.14 2.53%

Trend analysis of BioNTech SE balance sheet accounts such as Total Assets of 27.8 B, Short and Long Term Debt Total of 162.4 M or Other Current Liab of 751.8 M provides information on BioNTech's total assets, liabilities, and equity, which is the actual value of BioNTech SE to its prevalent stockholders. By breaking down trends over time using BioNTech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining BioNTech SE latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioNTech SE is a good buy for the upcoming year.

BioNTech Inventory

431.92 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About BioNTech Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of BioNTech SE at a specified time, usually calculated after every quarter, six months, or one year. BioNTech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of BioNTech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which BioNTech currently owns. An asset can also be divided into two categories, current and non-current.

BioNTech Balance Sheet Chart

At this time, BioNTech's Other Assets are fairly stable compared to the past year. Cash And Short Term Investments is likely to rise to about 20 B in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 162.4 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of BioNTech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BioNTech SE books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on BioNTech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of BioNTech SE are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from BioNTech's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into BioNTech SE current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	212.2M	219.1M	252.0M	162.4M
Total Assets	23.3B	23.0B	26.5B	27.8B

Short Long Term Debt Total Total Assets

BioNTech balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Long Term Investments	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other
Total Assets		0.78	0.86	0.84	1.0	0.98	0.73	-0.93	0.99	0.96	0.95	0.92	0.82	0.95	0.61	0.87	0.66	0.83	0.83	0.95	0.86	0.86	0.83	0.98	1.0	0.18
Short Long Term Debt Total	0.78		0.88	0.9	0.75	0.78	0.78	-0.64	0.72	0.75	0.64	0.64	0.5	0.63	0.74	0.6	0.84	0.52	0.59	0.86	0.77	0.9	0.5	0.76	0.78	0.56
Other Current Liab	0.86	0.88		0.98	0.84	0.8	0.52	-0.81	0.82	0.72	0.77	0.61	0.44	0.71	0.83	0.54	0.7	0.46	0.51	0.93	0.66	0.97	0.46	0.76	0.89	0.23
Total Current Liabilities	0.84	0.9	0.98		0.82	0.78	0.53	-0.73	0.79	0.72	0.7	0.6	0.45	0.66	0.9	0.54	0.7	0.48	0.54	0.95	0.62	1.0	0.46	0.75	0.87	0.17
Total Stockholder Equity	1.0	0.75	0.84	0.82		0.99	0.73	-0.94	1.0	0.96	0.97	0.93	0.84	0.97	0.57	0.88	0.65	0.85	0.84	0.93	0.87	0.84	0.85	0.98	0.99	0.17
Property Plant And Equipment Net	0.98	0.78	0.8	0.78	0.99		0.82	-0.92	0.98	0.99	0.96	0.96	0.87	0.97	0.51	0.92	0.7	0.88	0.87	0.91	0.93	0.81	0.88	1.0	0.97	0.29
Current Deferred Revenue	0.73	0.78	0.52	0.53	0.73	0.82		-0.61	0.72	0.86	0.68	0.85	0.81	0.75	0.26	0.86	0.7	0.82	0.84	0.66	0.94	0.57	0.81	0.84	0.7	0.68
Net Debt	-0.93	-0.64	-0.81	-0.73	-0.94	-0.92	-0.61		-0.94	-0.87	-0.98	-0.85	-0.74	-0.95	-0.43	-0.78	-0.59	-0.75	-0.69	-0.82	-0.82	-0.74	-0.76	-0.9	-0.93	-0.16
Retained Earnings	0.99	0.72	0.82	0.79	1.0	0.98	0.72	-0.94		0.96	0.97	0.93	0.85	0.98	0.54	0.89	0.62	0.86	0.85	0.92	0.86	0.82	0.86	0.98	0.99	0.14
Accounts Payable	0.96	0.75	0.72	0.72	0.96	0.99	0.86	-0.87	0.96		0.93	0.98	0.93	0.96	0.43	0.96	0.68	0.94	0.92	0.86	0.94	0.75	0.93	1.0	0.94	0.3
Cash	0.95	0.64	0.77	0.7	0.97	0.96	0.68	-0.98	0.97	0.93		0.91	0.82	0.99	0.41	0.86	0.59	0.82	0.77	0.83	0.87	0.72	0.83	0.94	0.95	0.18
Non Current Assets Total	0.92	0.64	0.61	0.6	0.93	0.96	0.85	-0.85	0.93	0.98	0.91		0.98	0.96	0.29	0.99	0.59	0.98	0.95	0.78	0.93	0.65	0.98	0.98	0.89	0.26
Non Currrent Assets Other	0.82	0.5	0.44	0.45	0.84	0.87	0.81	-0.74	0.85	0.93	0.82	0.98		0.9	0.13	0.99	0.46	1.0	0.96	0.65	0.86	0.51	1.0	0.91	0.78	0.18
Cash And Short Term Investments	0.95	0.63	0.71	0.66	0.97	0.97	0.75	-0.95	0.98	0.96	0.99	0.96	0.9		0.35	0.93	0.58	0.91	0.86	0.82	0.9	0.7	0.91	0.97	0.94	0.19
Net Receivables	0.61	0.74	0.83	0.9	0.57	0.51	0.26	-0.43	0.54	0.43	0.41	0.29	0.13	0.35		0.23	0.51	0.17	0.29	0.82	0.3	0.86	0.15	0.47	0.65	0.01
Good Will	0.87	0.6	0.54	0.54	0.88	0.92	0.86	-0.78	0.89	0.96	0.86	0.99	0.99	0.93	0.23		0.53	1.0	0.97	0.72	0.91	0.59	0.99	0.95	0.84	0.26
Common Stock Total Equity	0.66	0.84	0.7	0.7	0.65	0.7	0.7	-0.59	0.62	0.68	0.59	0.59	0.46	0.58	0.51	0.53		0.48	0.43	0.68	0.67	0.7	0.47	0.67	0.66	0.45
Short Term Investments	0.83	0.52	0.46	0.48	0.85	0.88	0.82	-0.75	0.86	0.94	0.82	0.98	1.0	0.91	0.17	1.0	0.48		0.97	0.67	0.86	0.54	1.0	0.92	0.8	0.19
Non Current Liabilities Total	0.83	0.59	0.51	0.54	0.84	0.87	0.84	-0.69	0.85	0.92	0.77	0.95	0.96	0.86	0.29	0.97	0.43	0.97		0.73	0.86	0.6	0.96	0.91	0.8	0.24
Inventory	0.95	0.86	0.93	0.95	0.93	0.91	0.66	-0.82	0.92	0.86	0.83	0.78	0.65	0.82	0.82	0.72	0.68	0.67	0.73		0.75	0.96	0.66	0.89	0.96	0.17
Other Current Assets	0.86	0.77	0.66	0.62	0.87	0.93	0.94	-0.82	0.86	0.94	0.87	0.93	0.86	0.9	0.3	0.91	0.67	0.86	0.86	0.75		0.66	0.86	0.93	0.84	0.59
Total Liab	0.86	0.9	0.97	1.0	0.84	0.81	0.57	-0.74	0.82	0.75	0.72	0.65	0.51	0.7	0.86	0.59	0.7	0.54	0.6	0.96	0.66		0.52	0.78	0.88	0.19
Long Term Investments	0.83	0.5	0.46	0.46	0.85	0.88	0.81	-0.76	0.86	0.93	0.83	0.98	1.0	0.91	0.15	0.99	0.47	1.0	0.96	0.66	0.86	0.52		0.92	0.79	0.18
Property Plant And Equipment Gross	0.98	0.76	0.76	0.75	0.98	1.0	0.84	-0.9	0.98	1.0	0.94	0.98	0.91	0.97	0.47	0.95	0.67	0.92	0.91	0.89	0.93	0.78	0.92		0.96	0.27
Total Current Assets	1.0	0.78	0.89	0.87	0.99	0.97	0.7	-0.93	0.99	0.94	0.95	0.89	0.78	0.94	0.65	0.84	0.66	0.8	0.8	0.96	0.84	0.88	0.79	0.96		0.16
Non Current Liabilities Other	0.18	0.56	0.23	0.17	0.17	0.29	0.68	-0.16	0.14	0.3	0.18	0.26	0.18	0.19	0.01	0.26	0.45	0.19	0.24	0.17	0.59	0.19	0.18	0.27	0.16

Click cells to compare fundamentals

BioNTech Account Relationship Matchups

BioNTech balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.3B	15.8B	23.3B	23.0B	26.5B	27.8B
Short Long Term Debt Total	240.2M	301.5M	212.2M	219.1M	252.0M	162.4M
Other Current Liab	487.6M	1.6B	2.1B	1.2B	1.4B	751.8M
Total Current Liabilities	606.0M	3.5B	3.0B	2.1B	2.4B	1.3B
Total Stockholder Equity	1.4B	11.9B	20.1B	20.2B	23.3B	24.4B
Other Liab	205.6M	97.1M	109.7M	283.9M	326.5M	166.9M
Net Tangible Assets	179.6M	406.5M	1.2B	11.7B	13.5B	14.1B
Property Plant And Equipment Net	326.0M	520.4M	821.1M	971.6M	1.1B	1.2B
Current Deferred Revenue	391.5M	189.1M	77.1M	353.3M	406.3M	426.6M
Net Debt	(970.0M)	(1.4B)	(13.7B)	(11.4B)	(10.3B)	(9.8B)
Retained Earnings	(409.6M)	9.9B	18.8B	19.8B	22.7B	23.9B
Accounts Payable	102.3M	160M	204.1M	354M	407.1M	427.5M
Cash	1.2B	1.7B	13.9B	11.7B	13.4B	14.1B
Non Current Assets Total	651.7M	758.5M	1.4B	3.5B	4.0B	4.2B
Non Currrent Assets Other	1.0M	800K	6.5M	187.1M	215.2M	225.9M
Other Assets	2.4M	168.2M	22.2M	249.2M	286.6M	300.9M
Long Term Debt	231.0M	171.6M	176.2M	191M	219.7M	116.1M
Cash And Short Term Investments	1.3B	2.1B	14.1B	16.5B	19.0B	20.0B
Net Receivables	166.4M	12.4B	7.1B	2.2B	2.5B	3.0B
Good Will	53.7M	57.8M	61.2M	362.5M	416.9M	437.7M
Common Stock Shares Outstanding	248.5M	259.7M	249.8M	242.7M	279.1M	229.1M
Short Term Investments	137.2M	381.6M	189.4M	4.9B	5.6B	5.9B
Liabilities And Stockholders Equity	2.3B	15.8B	23.3B	23.0B	26.5B	27.8B
Non Current Liabilities Total	340.8M	455.5M	272.9M	689.9M	793.4M	833.1M
Inventory	64.1M	502.5M	439.6M	357.7M	411.4M	431.9M
Other Current Assets	392.6M	113.8M	272.3M	460M	529M	555.5M
Other Stockholder Equity	1.8B	(3.8M)	(5.3M)	(10.8M)	(12.4M)	(11.8M)
Total Liab	946.8M	3.9B	3.2B	2.8B	3.2B	1.7B
Property Plant And Equipment Gross	326.0M	594.6M	821.1M	1.2B	1.4B	1.4B
Short Long Term Debt	9.1M	129.9M	36M	28.1M	32.3M	27.9M
Total Current Assets	1.7B	15.1B	21.9B	19.5B	22.5B	23.6B
Accumulated Other Comprehensive Income	25.5M	1.8B	979.3M	244.8M	281.5M	267.4M
Non Current Liabilities Other	263.1M	18.9M	23.1M	51.9M	59.7M	49.3M
Short Term Debt	15.2M	129.9M	36M	56.2M	64.6M	37.6M
Intangible Assets	109.8M	144.6M	158.5M	781.7M	899.0M	943.9M
Common Stock	232.3M	246.3M	246.3M	248.6M	285.9M	218.0M
Property Plant Equipment	116.0M	148.1M	326.0M	520.4M	598.5M	628.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioNTech Historical Balance Sheet

BioNTech Inventory

431.92 Million

About BioNTech Balance Sheet Analysis

BioNTech Balance Sheet Chart

Total Assets

Total Current Liabilities

BioNTech balance sheet Correlations

BioNTech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioNTech balance sheet Accounts

Also Currently Popular

Additional Tools for BioNTech Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Accumulated Amortization	Total Assets
Short Long Term Debt Total	Other Current Liab
Total Current Liabilities	Total Stockholder Equity
Other Liab	Net Tangible Assets
Property Plant And Equipment Net	Total Permanent Equity
Warrants	Current Deferred Revenue
Noncontrolling Interest In Consolidated Entity	Net Debt
Retained Earnings	Accounts Payable
Cash	Non Current Assets Total
Non Currrent Assets Other	Other Assets
Long Term Debt	Cash And Short Term Investments
Net Receivables	Good Will
Common Stock Total Equity	Retained Earnings Total Equity
Common Stock Shares Outstanding	Short Term Investments
Long Term Debt Total	Liabilities And Stockholders Equity
Non Current Liabilities Total	Capital Surpluse
Capital Lease Obligations	Negative Goodwill
Inventory	Other Current Assets
Other Stockholder Equity	Total Liab
Additional Paid In Capital	Deferred Long Term Liab
Preferred Stock Redeemable	Long Term Investments
Property Plant And Equipment Gross	Short Long Term Debt
Preferred Stock Total Equity	Total Current Assets
Accumulated Other Comprehensive Income	Treasury Stock
Non Current Liabilities Other	Accumulated Depreciation
Deferred Long Term Asset Charges	Short Term Debt
Intangible Assets	Common Stock
Temporary Equity Redeemable Noncontrolling Interests	Property Plant Equipment
Net Invested Capital	Net Working Capital
Capital Stock

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Retained Earnings	+ 1.0	Total Stockholder Equity
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Accounts Payable

Cash	- 0.98	Net Debt
Cash And Short Term Investments	- 0.95	Net Debt
Retained Earnings	- 0.94	Net Debt
Net Debt	- 0.94	Total Stockholder Equity
Total Current Assets	- 0.93	Net Debt
Net Debt	- 0.93	Total Assets